Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa

计划入组 720 人 · 首次发布于 2020 年 12 月 9 日

A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

计划入组 48 人 · 首次发布于 2013 年 1 月 9 日

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

计划入组 850 人 · 首次发布于 2020 年 4 月 14 日

LS-P2-VP8

TV P2-VP8 trivalent subunit vaccine

P2-VP8 subunit vaccine (PATH/ SK Chemicals)

VPI Pharmaceuticals Inc

Canada

Porcine Rotavirus Vaccines Face a Cross-Protection Gap as Reassortant Strains Emerge

Genentech Lays Off 103 Employees in Fifth Round of Cuts Since Mid-2025, Three VPs Among Casualties

Immunocore Restructures R&D Leadership as Executive VP Berman Departs